Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)
National Institutes of Health
Free. Verify your email, then we send one reminder only.
- Posted
- Oct 23, 2025
- Amount
- $1,000,000
- Closes
- Jun 17, 2027 (in 322 days)
Similar opportunities open now
- INCLUDE Project: Exploratory/Developmental Research Awards for Down syndrome (R21 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses Jun 2028Up to $200K
- Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)OpenNational Institutes of HealthCloses Jan 2028
- INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required)OpenNational Institutes of HealthCloses Jun 2028
- NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)OpenNational Institutes of HealthCloses Oct 2027
- Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)OpenNational Institutes of HealthCloses Jan 2028
Classification and identifiers
- Solicitation number
- RFA-DC-26-001
- Assistance listing (CFDA)
- 93.173
Amount
$1,000,000
Who can apply
Private colleges and universities, State government agencies, and Small businesses can all apply here. Check the eligibility details below to see if your organization fits.
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts. All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. This new requirement was effective, May 1, 2025.Applications involving for...
About this opportunity
The National Institute on Deafness and other Communication Disorders (NIDCD) intends to re-issue a Notice of Funding Opportunity (NOFO, prior funding opportunity RFA-DC-24-008 to solicit applications for research on early-stage dissemination and implementation (D&I) in the NIDCD mission areas of hearing, balance, taste, smell, voice, speech, and language. Much research is devoted to developing evidence-based innovations (EBIs) that improve a person"s health and quality of life. To impact people"s lives, EBIs need to be adopted in clinical practice and everyday life. Unfortunately, wide-scale adoption of EBIs is lengthy and rare. Dissemination and implementation (D&I) science is the field of research that seeks to close the gap between research and practice. Dissemination research is define...
Related opportunities
- INCLUDE Project: Exploratory/Developmental Research Awards for Down syndrome (R21 Clinical Trial Not Allowed)National Institutes of HealthCloses Jun 2028Up to $200K
- Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)National Institutes of HealthCloses Jan 2028
- INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required)National Institutes of HealthCloses Jun 2028
- NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)National Institutes of HealthCloses Oct 2027
- Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)National Institutes of HealthCloses Jan 2028
- Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)National Institutes of HealthCloses Jan 2028